|
Published by: Global Industry Analysts
Published: Oct. 1, 2008 - 960 Pages
Table of Contents
- I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Blood Components and Plasma Products
- Whole Blood & Cellular Components
- WBCs
- RBCs
- Platelets
- Plasma Fractions
- Fresh Frozen Plasma
- Albumin Fractions
- Factor VIII
- Factor IX and Factor IX Complex
- Fibrin/Thrombin
- Equipment, Blood Tests and Consumables
- Automated Analyzers for Blood Analysis
- Blood Tests
- Consumables
- II. EXECUTIVE SUMMARY
- 1.Market Overview
- Healthcare Scares Propel the Market
- Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
- Worldwide Blood Banking and Blood Products
- Market at a Glance
- Current & Future Analysis
- Analysis by Geographic Region
- Analysis by Product Segment
- World Blood Components and Plasma Market Analysis in Units
- Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for
- Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 2: World 10-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)
- Red Blood Cells - A Key Blood Component and a Major Contributor
- Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - USA, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 4: World 10-Year Perspective for Red Blood Cells
- by Region/Country - Percentage Breakdown of Volume Consumption for USA, Europe, Japan, and Rest of World Markets for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)
- 2.Market Trends & Issues
- New Infections - A Continuous Threat…
- Safety and Availability: The Core Issues
- Decontamination: A Viable Process
- New Processes for Safer Blood Supply
- Innovative Procedures Help Blood Conservation
- Autologous Transfusion Strapping up for High Growth
- Enzyme Converted Cells Set to Rule the Industry
- Blood Unavailability: Substitutes to the Rescue
- Transfusions: Hospitals Making Way for Others
- Computer Identification Helps Patients
- SARS: A Case of Mistaken Identity?
- Pooling: Economical HIV Testing
- Private Cord Blood Banking: Flying High Despite Opposition
- Consolidation Whittles Down Number of Market Players
- Table 5: Leading Players in World Market for Plasma Fractionation (2005): Percentage Breakdown of Fractionation Capacity for CSL Limited, Telecris, Baxter, Grifols, Octapharma and Others (includes corresponding Graph/Chart) Automation of Blood Banking - Nearing the Efficiency Frontier?
- Automated Instrumentation Taking the Front Seat
- Table 6: World Market for Blood Bank Technology (2004): Percentage Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation (includes corresponding Graph/Chart)
- Table 7: Leading Players in the World Market for Automated Collection of Blood Components using Apheresis Technology (2005): Percentage Breakdown of Revenues for Gambro, Baxter, Haemonetics, Fresenius, and Others (includes corresponding Graph/Chart)
- Plasma Market: Automation Making Inroads
- The RBC Market - Slow to Catch Up
- Automation of Testing - Yet to Mature
- Automation to Suffice Shortage Problems
- How Near to the Efficiency Frontier?
- 3.Product Overview
- Blood Banking and Blood Products Industry
- Blood Components and Plasma Products
- Equipment, Blood Tests and Consumables
- Automated Analyzers for Blood Analysis
- Blood Tests
- Consumables
- Blood Collection Equipment
- Blood Collection Monitors
- Blood Donor Couches
- Blood Processing Equipment
- Blood Bank Centrifuges
- Plasma Thawing
- Blood Cell Separators
- Blood Storage Equipment
- Blood Bags
- Platelet Agitators
- Blood Bank Refrigerators
- Blood - A Primer
- Ionic Structure
- Blood Components and their Applications
- Blood Constituents
- Plasma
- Red Blood Cells (RBC)
- Blood Count
- Platelets
- Table 8: Platelets (Leucodepleted) Issued by Select Region/ Agency (2005) (includes corresponding Graph/Chart)
- White Blood Cells (WBC)
- Derivative Products of Blood or Plasma Fractions
- Plasma Protein and Fractionation
- The Need
- Fresh Frozen Plasma
- Other Plasma Fractions
- Albumin Fractions
- Albumin Usage Rising in Profile, Wastage Worries
- Run Deep
- Immunoglobulins
- Table 9: Leading Countries in IVIg Usage Rates in
- Grams per 1000 Population (includes corresponding Graph/Chart)
- Hyper-Immune Immunoglobulin
- Factor VIII
- Table 10: Leading Players in World Market for Factor VIII (2006): Percentage Breakdown of Revenues for Baxter, Bayer (Kogenate), CSL Behring (Helixate) and Wyeth (includes corresponding Graph/Chart)
- Factor IX and Factor IX Complex
- Fibrin/Thrombin
- Consumption of Blood Based on Type of Surgery/
- Accident (In Units)
- Table 11: World Market for Plasma Derivatives (2005): Percentage Breakdown of Revenues by Region/Country - USA, Europe, Asia-Pacific, Latin America, and Rest of World (includes corresponding Graph/Chart)
- Table 12: World Market for Plasma Derivatives (2006): Percentage Breakdown of Revenues by Product Type - IVIg, Factor VIII, Albumin, Hyperimmunes, Factor IX and Others (includes corresponding Graph/Chart)
- Table 13: Plasma Collection in Select Countries in Thousand Liters (2005) (includes corresponding Graph/Chart)
- Recombinant Products
- Therapeutic Uses of Plasma Products
- Albumin Products
- Immunoglobulins
- Intravenous Immunoglobulin (IVIg)
- Normal Immunoglobulin (IMIg)
- CMV Immunoglobulin
- Hepatitis B Immunoglobulin
- Rh(D) Immunoglobulin
- Tetanus Immunoglobulin IM
- Zoster Immunoglobulin
- Plasma Derived Coagulant Products
- Biostate®
- Ceprotin®
- Factor VII Concentrate
- Factor XI Concentrates
- Feiba VH® Inhibitor Treatment
- Fibrogammin P®
- Monofix®-VF
- ProthrombinexTM-HT
- Thrombotrol®-VF
- 4.Blood Collection Methods
- Banking the Natural Blood Resources
- Blood Banks
- Blood Banking
- Blood Transfusion
- Role of Blood Banks
- Blood Donor: The Epicenter of the Process
- Eligibility Criteria for the Donor
- The Basics of Blood Donation - Myths Exploded &
- Other Facts
- Table 14: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/Agency (2004 & 2005) (includes corresponding Graph/Chart)
- Table 15: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (2005) (includes corresponding Graph/Chart)
- Collection Methods
- Blood Donation: The Process
- Types of Blood Donation
- Directed Blood Donations
- Autologous Blood Donation
- Alternative Usage of Patient’s Own Blood
- General Blood Donation
- Hemodilution
- Wound Drainage
- Cell Saver
- The Method
- Blood Salvaging
- Blood Collection Centers
- Blood Collection Management System
- A Historical Retrospective
- Blood Collection Centers
- Types of Blood Collection Centers
- Cord Blood Banks
- Profit Collection Centers
- Military Blood Banks
- Hospital Blood Banks
- Community Blood Banks
- Non-Profit Collection Centers
- Blood Processing
- Blood Typing
- Rh Blood Group System
- ABO Blood Group System
- Blood Types and their Compatibility
- Table 16: Occurrence of Blood Groups Worldwide
- (In %) (includes corresponding Graph/Chart)
- Blood Test
- Blood Culture
- The Costs
- History of Blood Banking
- 5.The Changing Landscape of Transfusion
- Technologies & Tests
- Blood Transfusion: A Backdrop
- Massive Transfusion
- Complications and Risks Due to Transfusion
- Circulatory Overload
- Graft Versus Host Disease (GVHD)
- Haemolytic Transfusion Reactions
- Iron Overload
- Bacterial Contamination
- Thrombophlebitis
- Allergic Reactions
- Air Embolism
- Hyperkalaemia
- Changing Role of Blood Banking Technology
- 6.Blood Transfusion: The Process, Tests/Technologies
- Cross Matching
- Blood Donor/Recipient Screening
- Blood Typing
- Leukoreduction
- Leukocyte Reduction Specification Standards/Filters
- Coombs Test
- 7.Alternatives to Blood Transfusion:
- A Real Threat to the Industry
- Bloodless Surgery
- Therapeutic Apheresis
- Plasmapheresis
- Plateletpheresis
- Leukapheresis
- Volume Expanders
- Colloids
- Albumin
- Dextrans
- Hydroxyethyl Starch
- Crystalloids
- Blood Growth Factor Therapies - Newer Alternatives to
- Transfusion
- 8.Blood Substitutes
- Blood Substitutes Under Development by Manufacturers
- Synthetic Blood Manufacturers/Developers
- Alliance Pharmaceuticals Corp. (USA)
- Biopure Corporation (USA)
- Enzon Pharmaceuticals (USA)
- Hemosol Inc. (Canada)
- Northfield Laboratories Inc. (USA)
- Synthetic Blood International, Inc. (USA)
- 9.Product Introductions/Innovations
- Gen-Probe Introduces APTIMA® HPV Assay
- Olympus AU680® Analyzer Offers an Automated
- HbA1c Assay
- Haemonetics Unveils New Plasma Collection Software
- Pall Unveils Acrodose™ PLus System
- Z-Medica Rolls Out Rapid Blood Clotting Products in the Consumer Market
- Dade Behring Launches the Quadriga BeFree System
- Swedish Inventors Develop New Processing System
- Canada Invents New Method for Monitoring
- Blood and Blood Products
- Terumo Launches Improvised Bags For Safe Blood
- Collection
- Haemonetics Launches Cymbal Automated Blood
- Collection System
- Illinois Inventors Introduces New Systems to
- Prepare Blood Products
- Abbott Unveils Two New Products for Blood Banks
- Cell Robotics Introduces New Lasette P 200
- Beckman’s COULTER® LH 750 Hematology Analyzers
- Hit the Market
- Haemonetics Unveils MCS®+ - Improved Red Cell
- Collection Technology
- Baxter Launches ALYX Component Collection System
- Grifols’ DG Gel® Revolutionizes Column Agglutination
- BioMérieux Introduces DAVINCI®…
- Pall Develops Novel Blood Filtration Membrane
- 10.Products in Pipeline & Technology Update
- From Clinical Trials to Clinics
- Cerus Receives CE Mark Approval for the Intercept
- Blood System for Platelets
- Haemonetics Wins FDA Approval for the ACP 215
- System
- Biomerieux’ Polycarbonate BacT/ALERT Receives
- US FDA Clearance
- Pall’s eBDS Receives Green Signal from FDA
- CardioPAT™ Surgical Blood Salvage System
- PCS® 2 - Set to Enhance Plasma Quality
- Dade Behring’s D-Dimer Assay Strapping up for Roll Out
- 11.Recent Industry Activity
- Global Med Technologies® Acquires eDonor®
- Immucor Snaps Up BioArray Solutions
- Global Med Technologies Acquires Inlog
- Gen-Probe to Acquire Innogenetics
- ProMetic to Hold Major Share in Pathogen Removal and
- Diagnostic Technologies
- ThermoGenesis Partners with GE Healthcare
- ThermoGenesis Ties Up with University of California
- Gambro Inks Preliminary Agreement with S.C.M S.r.l.
- ITL Extends Agreement with American Red Cross
- CSL Enters into Agreements with Héma-Québec and
- Canadian Blood Services
- Gambro Launches Bloodline Manufacturing Plant in
- Czech Republic
- Global Med Technologies® and Mid Coast Sign a License
- Agreement
- Global Med Technologies® Inks an Agreement with FBC
- ZymoGenetics Obtains FDA Approval for Marketing
- Recothrom
- CellaVision Enters into a Two-Year Manufacturing
- Agreement with Kitron AB
- VITA 34 and BKK Gruner + Jahr Sign Cooperation
- Agreement
- Haemonetics Bags FDA Clearance for eLynx
- Haemonetics Obtains FDA Approval for Symphony 2.0
- Software
- Thermogenesis Receives CE Mark Approval for
- Marrowxpress™
- Olympus PK 7300® Automated Microplate System Bags
- FDA Clearance
- ABL80 FLEX CO-OX Blood Gas Analyzer Receives
- FDA Clearance
- PK® Blood Grouping and Phenotyping Reagents Get
- FDA Approval
- Blood Banks with quality Transfusion Therapy to Come Up in Indian Metros
- Haemonetics Acquires Infonalé
- Gambro BCT Changes its Name to Caridian BCT
- Terumo Acquires Salymed
- Fresenius Takes Over Renal Solutions
- PerkinElmer Completes ViaCell Acquisition
- Texas Cord Blood Bank Expands Cord Blood Collection
- Network
- Inverness Medical Acquires HemoSense
- Haemonetics Acquires Haemoscope’ Hemostasis Analyzer
- Business Unit
- NxStage Medical Completes Medisystems Acquisition
- CordLife Establishes Cord Blood Bank in Indonesia
- Xinjiang Deyuan Begins Construction of a New Blood
- Product Plant
- Cord Blood America Acquires Curesource
- Grifols and Cerus Join Hands to Commercialize Cerus’
- Intercept Blood System
- Fresenius Kabi Signs Agreement to Acquire Kyorin
- Pharmaceutical
- Immucor and American Red Cross Ink Supply Agreement
- Haemonetics Signs Contract with Octapharma
- SFDA Revokes Drug Approval and Production Permit
- of Guangdong Bioyee
- Immucor Obtains Clearance from FDA for Marketing
- Galileo Echo
- Novartis Receives Approval for PROCLEIX® TIGRIS®
- System
- Thermogenesis Obtains FDA Approval for Autoxpress™
- CSL Receives Approval for Rhophylac®
- CSL Expands Haemate® P Business
- ViaCell to Expand ViaCord Processing Laboratory
- Cryobanks to Set Up a Cord Blood Bank in Thailand
- Grifols to Manage Four New Plasma Collection
- Centers in US
- Hualan Biological Acquires Chongqing Yituo
- CyGenics to Focus on Cord Blood Banking
- Cord Blood America Acquires CorCell
- Stemcyte to Establish Cord Blood Bank in India
- Baxter Divests Transfusion Therapies Business
- Cerus Obtains Approval for Intercept Blood System in
- Germany
- Cangene Obtains Health Canada Approval for
- Anti-Hepatitis B Blood Product
- Cord Blood America Inks Marketing Agreement with
- MSBCBS
- BCCL Acquires Stake in Life Cell
- bioMérieux and AdvanDx Sign Distribution Agreement for
- Rapid Diagnostic Tests
- Vita 34 International AG Expands Umbilical Cord
- Blood Banking Services
- Data Innovations to Develop Data Capture and Reporting
- System for Fenwal
- SunTech Medical Group Acquires Empirical Technologies
- Cord Blood America Acquires Cryobank
- Kalbe Acquires Stake in CyGenics’s Subsidiary
- CordLife Indonesia
- Cryobanks International Signs Letters of Intent with
- MedStem Services
- Cryobanks International Opens Cord Blood Stem Cell Bank
- DomaniCell Initiates Family Cord Blood Banking
- Program in Hospitals
- Cryobanks International Grants License for Cord
- Blood Processing System
- Community Blood Center Bags Contract
- Wilkes Medical Center Grants License for SafeTrace Tx
- Biosite Collaborates with HUG Research Hospital
- Pliva Terminates Agreement with Mayne
- Mississippi Blood Services Secures Contract
- APL Partners with Omscan
- DomaniCell Receives Stem Cell Banking License
- ThermoGenesis Enters into an Agreement with Cord
- Blood Registry
- ZLB Enters into Plasma Deal with BCA
- ViaCell and Pall Secure FDA Approval for ViaCord®
- Collection Kit
- Pall Secures Contract from NBS to Supply ‘Leukotrap’
- Filtration System
- Biotest and Sanquin to Form Joint Venture for Plasma
- Production
- Consorta Signs Partnership Agreement with GSABC
- Haemonetics Signs Supply Agreement with Canadian
- Blood Services
- Haemonetics Extends the Agreement with American
- Red Cross
- Novation and Abbott Enter into a Technology Agreement
- Olympus Redefines the Agreement with Biotest
- Cerus to Receive Marketing Rights over Baxter’s
- INTERCEPT Blood System
- CyGenics to Establish a New Cord Blood Banking
- Company
- UKCBB to Establish a Modern Laboratory in UMIC’s
- New CTF
- St. John’s Medical Center Procures Wyndgate’s
- SafeTrace Tx
- Florida`s Blood Centers Acquires South Florida
- Blood Banks
- BioStem Takes Over Cryobanks International
- FCBS Creates a Niche for itself by designing Cord Blood
- Stem Cells and Offers Public Donation Option
- Pall Signs Sale Agreement with Green Cross for
- Blood Filters
- TCBB Starts Collecting Donations for Cord Blood
- Pall Received FDA Clearance to Market New Pall
- Acrodose™ PL System
- CordLife Singapore Receives AABB Accreditation
- ITL and ARC Enter into an Agreement for Blood Bank
- Equipment
- NBA and UKT Merge to Form NHSBT
- BioMérieux and ExonHit Extend Collaboration to
- Develop Blood Diagnostics
- Wyndgate Signs Agreement with Cameron Hospital
- Daxor’s Subsidiary Wins Corporate Blood Banking Contract
- from Taglich Brothers
- Baxter and American Red Cross Enter Into Agreement
- CSL Signs Agreement with National Blood Authority
- Chiron Finds a South African Partner for Procleix®
- Tigris®
- ThermoGenesis and BHHTI Jointly Market CryoSeal FS
- Baxter and Cerus Enter into a Marketing Agreement
- Haemonetics Signs Technology Alliance with ZLB Plasma
- Services
- BioTime Collaborates with Summit Pharmaceuticals
- International Corp.
- SurgiLance Bags a Contract from America’s
- Blood Centers
- Florida’s Blood Centers Acquire Lake Park-based
- South Florida Blood Banks
- Global Med Technologies’ Division Signs Agreement with
- Hospital Partners of America
- Radiometer America and Consorta Extend Blood-Gas
- Products Deal
- Baxter's ALYX System Wins Medical Design
- Excellence Award
- Terumo Corp. Ups Stake in Blood Bag Venture
- Vita 34 International AG Takes over the Holdings of
- Corcell and Vita 34
- CSL Acquires Aventis Behring
- Medsurge Medical Products Corp. Buys Cryo Genomics
- Haemonetics’ Acquisition of Harvest Technologies Expands
- Surgical Blood Salvage Portfolio
- Chiron Buys Prion Solutions
- Celmed & Gambro Tie up for GvHD Prevention System
- Chiron Grants NAT Licenses to LabCorp and German
- Red Cross
- Sekisui Chemical Ventures into Chinese Blood Collection
- Market
- Stratec and Biotest Partner on the Development of
- a Blood Grouping Analyzer
- PRDT, ARC & Maco Pharma in a Strategic Alliance
- Pall’s Enhanced Bacterial Detection System to be
- Marketed by Kawasumi
- Baxter and Cerus Rope in Bioone Corp for Marketing
- Intercept
- Chiron Partners with ZymeQuest
- Pall Corporation Signs Agreement with Haemonetics
- Corporation
- Haemonetics Corporation & Hemosystem SA in a Marketing Alliance
- Chiron’s Armor Strengthened with Infectio’s Rapid
- Bacterial Detection Licenses
- Haemonetics, Braemed and Caster in a Marketing
- Agreement for Cell Saver® 5
- Haemonetics Obtains Marketing Licenses for
- Crit Scan®
- Lifebank Receives AABB Accreditation
- Bayer Divests Plasma Products Business to NPS
- ITL Receives FDA Clearance to Market SSK
- Chronix Biomedical Files Patent Approval for a New
- Diagnostic Test
- ViaCell’s Selective Amplification™ Program Boosts Cord
- Blood Banks’ Productivity
- CordLife Opens Second Cord Blood Banking Facility
- Singapore
- PharmaStem Inks Multiple Licensing Deals for Cord blood
- Preservation Technologies
- Novation Bags Big Ticket Deals for Blood Products
- 12.Focus on Select Global Players
- Leading Blood Banks
- AABB (USA)
- America’s Blood Centers (USA)
- American Red Cross (USA)
- Canadian Blood Services (Canada)
- CorCell Companies Inc. (USA)
- Cord Blood Registry (USA)
- Japan Red Cross (Japan)
- Lifebank Corp (Canada)
- National Blood Foundation (USA)
- New England Cord Blood Bank, Inc. (USA)
- New York Blood Center (USA)
- VITA 34 AG (Germany)
- Leading Players in Blood Bank Technology & Supplies
- Beckman Coulter Inc (USA)
- Becton Dickinson (USA)
- BioMerieux SA (France)
- Caridian BCT, Inc (USA)
- Chiron (USA)
- CSL Behring LLC (USA)
- Daxor Corporation (USA)
- Fenwal Inc., (USA)
- Fresenius SE (Germany)
- Gambro AB (Sweden)
- Gen-Probe Incorporated (USA)
- Haemonetics Corp., (USA)
- Hemagen Diagnostics Inc. (USA)
- Immucor Inc. (USA)
- Kawasumi Laboratories, Inc. (Japan)
- Olympus America, Inc. (USA)
- PharmaStem Therapeutics, Inc. (USA)
- Terumo Corporation (Japan)
- ThermoGenesis Corp. (USA)
- ZymeQuest, Inc. (USA)
- Leading Players in Plasma Fractionation
- Baxter International Inc. (USA)
- Bio Products Laboratory (UK)
- CSL Limited (Australia)
- CSL Bioplasma (Australia)
- Grifols (Spain)
- Kedrion (Italy)
- Laboratoire Français du Fractionnement et des
- Biotechnologies (France)
- Octapharma (Switzerland)
- Sanquin (The Netherlands)
- Talecris Biotherapeutics (USA)
- 13.Global Market Perspective
- Table 17: World Recent Past, Current & Future Analysis
- for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for
- Years 2001 through 2010 (includes corresponding
- Graph/Chart)
- Table 18: World Long-term Projections for Blood
- Banking and Blood Products by Geographic Region -
- USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million
- for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 19: World Historic Review for Blood Banking and Blood Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 20: World 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets
- for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- Table 21: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 22: World Long-term Projections for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 23: World Historic Review for Blood Components and Plasma Products by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 24: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 25: World Long-term Projections for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 26: World Historic Review for Blood Components and Plasma Products by Product Group - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 27: World 15-Year Perspective for Blood Components
- and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- Table 28: World 15-Year Perspective for Blood Components and Plasma Products by Product Group - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 1998, 2008 & 2012
- Table 29: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 30: World Long-term Projections for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 31: World Historic Review for Whole Blood & Cellular Components by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and
- Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 32: World 15-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of
- World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- Table 33: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - USA, Canada,
- Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with
- Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 34: World Long-term Projections for Plasma Fractions
- by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 35: World Historic Review for Plasma Fractions by Geographic Region - USA, Canada, Japan, Europe,
- Asia-Pacific (excluding Japan), Latin America and Rest of
- World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000
- (includes corresponding Graph/Chart)
- Table 36: World 15-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998,
- 2008 & 2012 (includes corresponding Graph/Chart)
- Table 37: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million
- for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 38: World Long-term Projections for Equipment,
- Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million
- for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 39: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 40: World 15-Year Perspective for Equipment, Blood
- Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada,
- Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- III. MARKET
- 1.The United States
- A. Market Analysis
- Current and Future Analysis
- Market Trends
- US Blood Collection & Supply Profile
- Blood Group Distribution
- Table 41: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart)
- Table 42: Percentage Break up of Rh Blood Types in the US by Racial Group
- Blood Donated and Transfused Every Year
- Males Form the Major Chunk of Donors
- Cost of Blood
- SARS Scares: Blood Banks Feel the Heat
- Blood and Blood Preparations: Trade Statistics
- Table 43: US Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by Country - Germany, UK, Canada, Switzerland, Belgium and
- Others (In US$ Million) (includes corresponding Graph/Chart)
- Table 44: US Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country - Germany, Netherlands, UK, Switzerland, Canada and Others (In US$ Million) (includes corresponding Graph/Chart)
- Whole Human Blood: Export-Import Scenario in the Recent Past
- Table 45: US Market for Whole Human Blood
- (2003 & 2004): Percentage Breakdown of Volume Exports by Country - France, Canada, UK, Germany, Japan, Taiwan, Korea, Belgium, Netherlands, Italy,
- Peru, and Others (includes corresponding
- Graph/Chart)
- Table 46: US Market for Whole Human Blood (2003 & 2004): Percentage Breakdown of Value Exports by Country - France, UK, Germany, Japan, Canada, Belgium, Korea, Peru, Taiwan, Netherlands, Italy, and Others (includes corresponding Graph/Chart)
- Table 47: US Market for Whole Human Blood
- (2003 & 2004): Percentage Breakdown of
- Volume Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)
- Table 48: US Market for Whole Human Blood
- 2003 & 2004): Percentage Breakdown of Consumption
- of Value Imports by Country - Japan, UK, Germany, Indonesia, and Canada (includes corresponding Graph/Chart)
- US Blood Components and Plasma Market Analysis in Units
- Table 49: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 50: US 10-Year Perspective for Blood
- Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for
- Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2001, 2008 & 2010 (includes corresponding Graph/Chart)
- Regulations Control Plasma Collection Industry
- Product Launches/Developments
- Strategic Corporate Developments
- Select Players
- Blood Banks
- AABB
- America’s Blood Centers
- American Red Cross
- Blood Bank of Alaska
- California Cryobank
- Family Cord Blood Services Inc.
- Community Blood Bank
- CorCell Companies Inc.
- Cord Blood Registry
- National Blood Foundation
- New England Cord Blood Bank, Inc.
- New York Blood Center
- Oklahoma Blood Institute
- Blood Bank Technology Developers and
- Consumables Suppliers
- Beckman Coulter Inc.
- Becton, Dickinson and Company
- Caridian BCT, Inc
- Chiron
- CSL Behring LLC (USA)
- Daxor Corporation
- Fenwal Inc.,
- Gen-Probe Incorporated
- Haemonetics Corp.,
- Hemagen Diagnostics Inc.
- Immucor Inc.
- Olympus America, Inc.
- Pall Corporation
- PharmaStem Therapeutics, Inc.
- ThermoGenesis Corp.
- ViaCell, Inc.
- ZymeQuest, Inc.
- Major Plasma Fractionators
- Baxter International Inc.
- Talecris Biotherapeutics
- B. Market Analytics
- Table 51: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 52: US Long-term Projections for Blood Banking
- and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment,
- Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 53: US Historic Review for Blood Banking and
- Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 54: US 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 2.Canada
- A. Market Analysis
- Current and Future Analysis
- Blood Facts
- Bleeding Disorders - A Major Threat
- The ‘CSA-Z 902-04’ - A Comprehensive Voluntary
- Blood Safety Standard
- Blood and Blood Preparations: Import & Export
- Scenario
- Table 55: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Import Sources by
- Country - US, The Netherlands, Switzerland,
- Belgium, Italy and Others (In US$ Million) (includes corresponding Graph/Chart)
- Table 56: Canadian Blood and Blood Preparations Market (2006 & 2007): Major Export Destinations by Country - US, France, Chile, Belgium, Germany and Others (In US$ Million) (includes corresponding Graph/Chart)
- Product Launches/Developments
- Strategic Corporate Developments
- Select Players
- LifeBank
- Canadian Blood Services
- The Canadian Hemophilia Society (CHS)
- B. Market Analytics
- Table 57: Canadian Recent Past, Current & Future
- Analysis for Blood Banking and Blood Products by
- Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 58: Canadian Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood and Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 59: Canadian Historic Review for Blood Banking
- and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 60: Canadian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 3.Japan
- A. Market Analysis
- Current and Future Analysis
- Growing Market for Fresh Frozen Plasma
- Strategic Corporate Developments
- Select Players
- Japan Red Cross
- Kawasumi Laboratories, Inc.
- Terumo Corporation
- B. Market Analytics
- Table 61: Japanese Recent Past, Current & Future
- Analysis for Blood Banking and Blood Products by
- Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 62: Japanese Long-term Projections for
- Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma
- Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and
- Other Consumables Markets Independently Analyzed
- with Annual Sales Figures in US$ Million for Years
- 2011 through 2015 (includes corresponding
- Graph/Chart)
- Table 63: Japanese Historic Review for Blood Banking
- and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures
- in US$ Million for Years 1991 through 2000
- (includes corresponding Graph/Chart)
- Table 64: Japanese 15-Year Perspective for Blood
- Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables
- Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 4.Europe
- A. Market Analysis
- Current & Future Analysis
- Analysis by Geographic Region
- European Blood Banking and Blood Products Market at a Glance (All figures are 2008 estimates & CAGR is for the period 2001-2010)
- Analysis by Product Segment
- Market Trends and Issues
- Legislations on Payment for Donation Restrict
- Donors
- Government’s Check on Healthcare Costs Pressurizes
- BCT Manufacturers
- Purchasing System Witnesses Modifications
- EU Nations Marching Towards Self-Sufficiency in
- Blood and Blood Products
- Blood Banking Devices Market
- Table 65: European Recent Past, Current & Future Analysis for Blood Banking Devices by Product
- Segment - Manual Blood Collection, Apheresis, and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding
- Graph/Chart)
- Table 66: European Long-term Projections Blood Banking Devices by Product Segment - Manual Blood Collection, Apheresis, and Autologous Devices Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 67: European 10-Year Perspective for Blood Banking Devices by Product Segment - Manual Blood Collection, Apheresis, and Autologous Devices Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
- Table 68: European Blood Banking Devices Market (2007): Percentage Breakdown of Value Sales by Geographic Region for France, Germany, Italy, UK, Spain and Rest of Europe (includes corresponding Graph/Chart)
- A Snapshot of Health Care Systems Across Select
- EU Countries
- France
- Germany
- Italy
- The UK
- Spain
- Product Launches/Developments
- Strategic Corporate Developments
- B. Market Analytics
- Table 69: European Recent Past, Current & Future
- Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK,
- Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million
- for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 70: European Long-term Projections for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 71: European Historic Review for Blood Banking
- and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 72: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in
- US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 73: European Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 74: European Historic Review for Blood Banking
- and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 75: European 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- Table 76: European 15-Year Perspective for Blood
- Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998,
- 2008 & 2012 (includes corresponding Graph/Chart)
- 4a.France
- A. Market Analysis
- Current and Future Analysis
- Competitive Scenario
- Table 77: Leading Players in the French Blood
- Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Kedrion, Baxter, and Others (includes corresponding Graph/Chart)
- Select Players
- BioMérieux SA
- Laboratoire Français du Fractionnement et des
- Biotechnologies
- B. Market Analytics
- Table 78: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 79: French Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 80: French Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 81: French 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 4b.Germany
- A. Market Analysis
- Current and Future Analysis
- Competitive Scenario
- Table 82: Leading Players in the German Blood
- Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for ZLB Behring, Baxter, Bayer and Others (includes corresponding Graph/Chart)
- Strategic Corporate Developments
- Select Players
- Fresenius SE
- VITA 34 AG
- B. Market Analytics
- Table 83: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 84: German Long-term Projections for Blood
- Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in
- US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 85: German Historic Review for Blood Banking
- and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment,
- Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 86: German 15-Year Perspective for Blood
- Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 4c.Italy
- A. Market Analysis
- Current and Future Analysis
- Kedrion - A Major Italian Fractionator
- B. Market Analytics
- Table 87: Italian Recent Past, Current & Future
- Analysis for Blood Banking and Blood Products by
- Product Group /Segment - Blood Components and
- Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently
- Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 88: Italian Long-term Projections for Blood
- Banking and Blood Products by Product Group/
- Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 89: Italian Historic Review for Blood Banking
- and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets
- Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 90: Italian 15-Year Perspective for Blood
- Banking and Blood Products by Product Group/
- Segment - Percentage Breakdown of Value Sales
- for Blood Components and Plasma Products
- (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 4d.The United Kingdom
- A. Market Analysis
- Current and Future Analysis
- Blood Requirements
- Competitive Scenario
- Table 91: Leading Players in the UK Blood
- Banking Devices and Plasma Products Market
- (2003 & 2004) - Percentage Breakdown of
- Revenues for Bio Products Laboratory, Baxter,
- Grifols, and Others (includes corresponding Graph/Chart)
- Select Players
- Bio Products Laboratory
- Surgical Innovations Group Plc
- B. Market Analytics
- Table 92: UK Recent Past, Current & Future Analysis
- for Blood Banking and Blood Products by Product
- Group/Segment - Blood Components and Plasma
- Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and
- Other Consumables Markets Independently Analyzed
- with Annual Sales Figures in US$ Million for
- Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 93: UK Long-term Projections for Blood Banking
- and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in
- US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 94: UK Historic Review for Blood Banking and
- Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumable Markets Independently Analyzed with Annual Sales Figures in
- US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 95: UK 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 4e.Spain
- A. Market Analysis
- Current and Future Analysis
- Competitive Scenario
- Table 96: Leading Players in the Spanish Blood
- Banking Devices and Plasma Products Market (2004) - Percentage Breakdown of Revenues for Baxter, Grifols, ZLB Behring, and Others (includes corresponding Graph/Chart)
- Grifols - A Major Player
- B. Market Analytics
- Table 97: Spanish Recent Past, Current & Future
- Analysis for Blood Banking and Blood Products by
- Product Group/ Segment - Blood Components and
- Plasma Products (Whole Blood & Cellular
- Components, and Plasma Fractions); and Equipment,
- Blood Tests and Other Consumables Markets
- Independently Analyzed with Annual Sales Figures
- in US$ Million for Years 2001 through 2010
- (includes corresponding graph/Chart)
- Table 98: Spanish Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment,
- Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 99: Spanish Historic Review for Blood Banking
- and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 100: Spanish 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 4f.Russia
- Market Analysis
- Table 101: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 102: Russian Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 103: Russian Historic Review for Blood Banking
- and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment,
- Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 104: Russian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 4g.Rest of Europe
- A. Market Analysis
- Current and Future Analysis
- Denmark - High Participation and Consumption
- of Blood
- Strategic Corporate Developments
- Select Players
- Gambro AB (Sweden)
- Octapharma (Switzerland)
- Sanquin (The Netherlands)
- B. Market Analytics
- Table 105: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 106: Rest of Europe Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 107: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 108: Rest of Europe 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 5.Asia-Pacific
- A. Market Analysis
- Current and Future Analysis
- ASEAN - Striding Towards Standardization of
- Blood Supply
- Australia
- Role of National Blood Authority
- China - A Key Market
- Government Wakes Up to Realities
- Table 109: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)
- Table 110: Chinese Market for Blood Banking & Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female
- Table 111: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, & 61-70 (includes corresponding Graph/Chart)
- India
- Healthy Rise in Indian Blood Bank Market
- Regularization of Indian Cord Blood Banks
- Indonesia
- Strategic Corporate Developments
- Select Players
- CSL Limited (Australia)
- CSL Bioplasma (Australia)
- Indian Red Cross Society (India)
- ITL Limited (Australia)
- Rajkot Voluntary Blood Bank (India)
- B. Market Analytics
- Table 112: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 113: Asia-Pacific Long-term Projections for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 114: Asia-Pacific Historic Review for Blood
- Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 115: Asia-Pacific 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 6.Latin America
- A. Market Analysis
- Current and Future Analysis
- Strategic Corporate Development
- B. Market Analytics
- Table 116: Latin American Recent Past, Current &
- Future Analysis for Blood Banking and Blood
- Products by Product Group/Segment - Blood
- Components and Plasma Products (Whole Blood &
- Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables
- Markets Independently Analyzed with Annual
- Sales Figures in US$ Million for Years 2001
- through 2010 (includes corresponding
- Graph/Chart)
- Table 117: Latin American Long-term Projections for
- Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products
- (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with
- Annual Sales Figures in US$ Million for Years
- 2011 through 2015 (includes corresponding
- Graph/Chart)
- Table 118: Latin American Historic Review for
- Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma
- Products (Whole Blood & Cellular Components,
- and Plasma Fractions); and Equipment, Blood
- Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million
- for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 119: Latin American 15-Year Perspective for
- Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales
- for Blood Components and Plasma Products (Whole
- Blood & Cellular Components, and Plasma Fractions);
- and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- 7.Rest of World
- A. Market Analysis
- Current and Future Analysis
- Strategic Corporate Development
- B. Market Analytics
- Table 120: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart)
- Table 121: Rest of World Long-term Projections for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
- Table 122: Rest of World Historic Review for Blood
- Banking and Blood Products by Product Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment,
- Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
- Table 123: Rest of World 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart)
- IV. COMPETITIVE LANDSCAPE
AbstractThis report analyzes the worldwide markets for Blood Banking & Blood Products in Millions of US$. The specific product segments analyzed are Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 206 companies, including leading blood banks such as AABB, America’s Blood Centers, American Red Cross, Canadian Blood Services, CorCell Companies, Inc., Cord Blood Registry, Japan Red Cross, Lifebank Corp, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, and VITA 34 AG.
Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring, Daxor Corporation, Fenwal Inc., Fresenius SE, Gambro AB, Gen-Probe Incorporated, Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and ZymeQuest, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Bio Products Laboratory, CSL Limited, CSL Bioplasma, Grifols, Kedrion, Laboratorie Francais du Fractionnement et des Biotechnologies, Octapharma, Sanquin, and Talecris Biotherapeutics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
